Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hepatoblastoma | 9 | 2023 | 88 | 2.170 |
Why?
|
Gastrointestinal Stromal Tumors | 4 | 2016 | 615 | 1.070 |
Why?
|
Gastrointestinal Neoplasms | 3 | 2016 | 951 | 0.870 |
Why?
|
Adrenal Gland Neoplasms | 3 | 2022 | 733 | 0.850 |
Why?
|
Bupivacaine | 2 | 2018 | 413 | 0.810 |
Why?
|
Intestinal Obstruction | 3 | 2023 | 434 | 0.790 |
Why?
|
Peritoneal Dialysis | 2 | 2013 | 157 | 0.780 |
Why?
|
Aptamers, Nucleotide | 1 | 2023 | 172 | 0.780 |
Why?
|
Liver Neoplasms | 10 | 2023 | 4319 | 0.760 |
Why?
|
Splenectomy | 3 | 2020 | 391 | 0.720 |
Why?
|
Ovariectomy | 3 | 2019 | 611 | 0.700 |
Why?
|
Child | 67 | 2024 | 79806 | 0.670 |
Why?
|
Anesthetics, Local | 2 | 2018 | 1001 | 0.640 |
Why?
|
Ovarian Neoplasms | 5 | 2021 | 4878 | 0.620 |
Why?
|
Rectal Diseases | 1 | 2019 | 144 | 0.600 |
Why?
|
Drug Delivery Systems | 2 | 2023 | 2221 | 0.570 |
Why?
|
Bone Neoplasms | 3 | 2024 | 2532 | 0.560 |
Why?
|
Myasthenia Gravis | 2 | 2017 | 213 | 0.560 |
Why?
|
Certification | 1 | 2020 | 421 | 0.560 |
Why?
|
Neoplasms, Second Primary | 2 | 2019 | 1056 | 0.560 |
Why?
|
Thymectomy | 1 | 2017 | 194 | 0.540 |
Why?
|
Osteosarcoma | 3 | 2024 | 897 | 0.520 |
Why?
|
Adrenal Cortex Neoplasms | 2 | 2021 | 161 | 0.500 |
Why?
|
Liposomes | 1 | 2018 | 777 | 0.480 |
Why?
|
Preoperative Care | 5 | 2019 | 2256 | 0.460 |
Why?
|
Child, Preschool | 38 | 2024 | 42063 | 0.440 |
Why?
|
Renal Insufficiency | 2 | 2021 | 820 | 0.410 |
Why?
|
Infant | 32 | 2024 | 36060 | 0.410 |
Why?
|
Rectum | 2 | 2009 | 895 | 0.410 |
Why?
|
Hernia, Inguinal | 3 | 2021 | 220 | 0.400 |
Why?
|
Pediatrics | 4 | 2020 | 3586 | 0.400 |
Why?
|
Spleen | 1 | 2018 | 2298 | 0.390 |
Why?
|
Gastrectomy | 1 | 2016 | 679 | 0.390 |
Why?
|
Catheters, Indwelling | 2 | 2021 | 428 | 0.390 |
Why?
|
Catheterization | 2 | 2016 | 1432 | 0.390 |
Why?
|
Survivors | 4 | 2023 | 2375 | 0.390 |
Why?
|
General Surgery | 2 | 2014 | 1678 | 0.380 |
Why?
|
Adolescent | 39 | 2024 | 87810 | 0.380 |
Why?
|
Polyglycolic Acid | 1 | 2012 | 405 | 0.360 |
Why?
|
Analgesia | 1 | 2014 | 459 | 0.350 |
Why?
|
Pancreatic Neoplasms | 4 | 2021 | 5351 | 0.350 |
Why?
|
Rectovaginal Fistula | 1 | 2009 | 12 | 0.350 |
Why?
|
Sutures | 1 | 2012 | 293 | 0.340 |
Why?
|
Neoplasms | 9 | 2023 | 22072 | 0.340 |
Why?
|
Intestinal Atresia | 1 | 2009 | 69 | 0.330 |
Why?
|
Pylorus | 1 | 2009 | 86 | 0.330 |
Why?
|
Situs Inversus | 1 | 2009 | 63 | 0.330 |
Why?
|
Tibial Arteries | 1 | 2009 | 60 | 0.320 |
Why?
|
Focal Nodular Hyperplasia | 1 | 2008 | 29 | 0.320 |
Why?
|
Femoral Neoplasms | 1 | 2009 | 82 | 0.320 |
Why?
|
Urinary Bladder Diseases | 1 | 2009 | 169 | 0.320 |
Why?
|
Splenic Diseases | 2 | 2020 | 90 | 0.320 |
Why?
|
Retrospective Studies | 33 | 2024 | 80372 | 0.310 |
Why?
|
Pulmonary Blastoma | 1 | 2008 | 41 | 0.310 |
Why?
|
Nanomedicine | 1 | 2011 | 288 | 0.310 |
Why?
|
Mesentery | 1 | 2009 | 202 | 0.300 |
Why?
|
Humans | 108 | 2024 | 760621 | 0.300 |
Why?
|
Infant, Newborn | 20 | 2021 | 26181 | 0.300 |
Why?
|
Intestinal Volvulus | 1 | 2009 | 81 | 0.300 |
Why?
|
Abnormalities, Multiple | 3 | 2009 | 1415 | 0.300 |
Why?
|
Cardiac Surgical Procedures | 3 | 2013 | 3620 | 0.300 |
Why?
|
Tumor Necrosis Factor-alpha | 11 | 2010 | 4357 | 0.300 |
Why?
|
Neuroblastoma | 2 | 2023 | 1252 | 0.300 |
Why?
|
Choristoma | 1 | 2009 | 207 | 0.300 |
Why?
|
Self Report | 1 | 2019 | 3711 | 0.300 |
Why?
|
Hypertension, Pulmonary | 1 | 2018 | 1570 | 0.300 |
Why?
|
Critical Care | 1 | 2020 | 2699 | 0.290 |
Why?
|
Diseases in Twins | 1 | 2009 | 447 | 0.290 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 9 | 2024 | 11712 | 0.290 |
Why?
|
Soft Tissue Neoplasms | 2 | 2022 | 1152 | 0.280 |
Why?
|
Lactic Acid | 1 | 2012 | 1134 | 0.280 |
Why?
|
Anal Canal | 1 | 2009 | 372 | 0.280 |
Why?
|
Ureter | 1 | 2009 | 375 | 0.280 |
Why?
|
Hypnotics and Sedatives | 1 | 2014 | 1178 | 0.270 |
Why?
|
Drug Resistance, Neoplasm | 5 | 2008 | 5253 | 0.270 |
Why?
|
Apoptosis | 10 | 2005 | 9501 | 0.270 |
Why?
|
Saphenous Vein | 1 | 2009 | 537 | 0.260 |
Why?
|
Guideline Adherence | 1 | 2016 | 2283 | 0.250 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2009 | 294 | 0.250 |
Why?
|
Cause of Death | 2 | 2018 | 3725 | 0.250 |
Why?
|
Breast Neoplasms | 12 | 2010 | 21025 | 0.250 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2009 | 586 | 0.240 |
Why?
|
Lung Neoplasms | 5 | 2024 | 13262 | 0.240 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 2 | 2006 | 687 | 0.240 |
Why?
|
Neoplasm Staging | 6 | 2021 | 11152 | 0.240 |
Why?
|
Female | 57 | 2024 | 391270 | 0.240 |
Why?
|
Cell Survival | 8 | 2010 | 5797 | 0.230 |
Why?
|
Vagina | 1 | 2009 | 837 | 0.230 |
Why?
|
Stress, Psychological | 1 | 2019 | 4446 | 0.230 |
Why?
|
Liver Transplantation | 3 | 2023 | 2325 | 0.220 |
Why?
|
Vincristine | 5 | 2023 | 1039 | 0.220 |
Why?
|
Prenatal Diagnosis | 2 | 2012 | 1264 | 0.220 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2005 | 331 | 0.220 |
Why?
|
Hematopoietic Stem Cell Transplantation | 3 | 2019 | 5649 | 0.220 |
Why?
|
Male | 50 | 2024 | 359744 | 0.220 |
Why?
|
Pleural Neoplasms | 1 | 2008 | 609 | 0.220 |
Why?
|
Protein Kinase C | 2 | 2005 | 1199 | 0.210 |
Why?
|
Intestine, Small | 1 | 2009 | 1207 | 0.210 |
Why?
|
Chemotherapy, Adjuvant | 5 | 2022 | 3529 | 0.210 |
Why?
|
Peritoneal Neoplasms | 1 | 2009 | 707 | 0.200 |
Why?
|
Young Adult | 15 | 2024 | 58741 | 0.200 |
Why?
|
Sodium Channel Blockers | 1 | 2023 | 172 | 0.200 |
Why?
|
Tetrodotoxin | 1 | 2023 | 246 | 0.200 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 2 | 2021 | 494 | 0.200 |
Why?
|
Estrogen Receptor alpha | 4 | 2012 | 580 | 0.200 |
Why?
|
Incidence | 10 | 2021 | 21392 | 0.200 |
Why?
|
Advanced Cardiac Life Support | 1 | 2002 | 78 | 0.190 |
Why?
|
Referral and Consultation | 1 | 2014 | 3598 | 0.190 |
Why?
|
Postoperative Complications | 6 | 2021 | 15697 | 0.190 |
Why?
|
Piperazines | 1 | 2012 | 2525 | 0.190 |
Why?
|
Hernia, Femoral | 1 | 2021 | 18 | 0.190 |
Why?
|
Intensive Care Units | 1 | 2014 | 3736 | 0.190 |
Why?
|
Paraganglioma | 1 | 2022 | 142 | 0.180 |
Why?
|
Follow-Up Studies | 12 | 2024 | 39261 | 0.180 |
Why?
|
Organic Chemicals | 1 | 2001 | 211 | 0.180 |
Why?
|
Tumor Cells, Cultured | 9 | 2005 | 6131 | 0.180 |
Why?
|
Adrenocortical Carcinoma | 1 | 2021 | 88 | 0.180 |
Why?
|
Acute Kidney Injury | 1 | 2012 | 1941 | 0.180 |
Why?
|
Appendectomy | 2 | 2020 | 431 | 0.180 |
Why?
|
Carcinoma, Hepatocellular | 3 | 2023 | 2299 | 0.180 |
Why?
|
Intestines | 1 | 2009 | 1907 | 0.170 |
Why?
|
Wilms Tumor | 1 | 2023 | 375 | 0.170 |
Why?
|
Pheochromocytoma | 1 | 2022 | 328 | 0.170 |
Why?
|
Estrogens | 3 | 2010 | 1520 | 0.170 |
Why?
|
Pyrimidines | 1 | 2012 | 3016 | 0.170 |
Why?
|
Hernia, Umbilical | 1 | 2021 | 102 | 0.170 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2002 | 642 | 0.170 |
Why?
|
Antibiotic Prophylaxis | 1 | 2005 | 643 | 0.170 |
Why?
|
Prognosis | 12 | 2022 | 29658 | 0.170 |
Why?
|
Pain | 1 | 2014 | 5066 | 0.170 |
Why?
|
Chronic Disease | 4 | 2023 | 9287 | 0.170 |
Why?
|
Delayed-Action Preparations | 1 | 2023 | 961 | 0.170 |
Why?
|
Gallbladder Diseases | 1 | 2020 | 137 | 0.160 |
Why?
|
Flavones | 2 | 2012 | 68 | 0.160 |
Why?
|
NF-kappa B | 3 | 2004 | 2488 | 0.160 |
Why?
|
Biopsy | 6 | 2020 | 6771 | 0.160 |
Why?
|
Sulfones | 1 | 2001 | 447 | 0.160 |
Why?
|
Micelles | 1 | 2018 | 192 | 0.150 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2024 | 2007 | 0.150 |
Why?
|
Teratoma | 1 | 2021 | 403 | 0.150 |
Why?
|
Nevus, Epithelioid and Spindle Cell | 1 | 2019 | 70 | 0.150 |
Why?
|
Cholecystectomy | 1 | 2020 | 406 | 0.150 |
Why?
|
Resource Allocation | 1 | 2020 | 349 | 0.150 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 2 | 2016 | 367 | 0.150 |
Why?
|
Testicular Diseases | 1 | 2018 | 73 | 0.150 |
Why?
|
End Stage Liver Disease | 1 | 2022 | 353 | 0.150 |
Why?
|
Laparoscopy | 2 | 2020 | 2147 | 0.150 |
Why?
|
Epoprostenol | 1 | 2018 | 248 | 0.150 |
Why?
|
Risk Factors | 11 | 2023 | 74359 | 0.150 |
Why?
|
Anesthetics | 1 | 2023 | 522 | 0.140 |
Why?
|
United States | 14 | 2024 | 72461 | 0.140 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2016 | 9276 | 0.140 |
Why?
|
Hernia, Ventral | 1 | 2021 | 214 | 0.140 |
Why?
|
Radiopharmaceuticals | 2 | 2024 | 2634 | 0.140 |
Why?
|
Catheterization, Central Venous | 1 | 2021 | 526 | 0.140 |
Why?
|
Colon | 1 | 2005 | 1788 | 0.140 |
Why?
|
Cisplatin | 4 | 2021 | 1644 | 0.140 |
Why?
|
Glomus Tumor | 1 | 2017 | 62 | 0.140 |
Why?
|
Bacterial Infections | 1 | 2005 | 1403 | 0.140 |
Why?
|
Electron Transport Complex II | 1 | 2016 | 53 | 0.140 |
Why?
|
MAP Kinase Kinase 5 | 2 | 2008 | 10 | 0.140 |
Why?
|
Survival Analysis | 4 | 2013 | 10182 | 0.130 |
Why?
|
Injections, Intravenous | 1 | 2018 | 1385 | 0.130 |
Why?
|
Nitriles | 1 | 2001 | 956 | 0.130 |
Why?
|
Membrane Glycoproteins | 2 | 2004 | 3707 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-kit | 2 | 2016 | 727 | 0.130 |
Why?
|
Protein Kinase Inhibitors | 2 | 2012 | 5643 | 0.130 |
Why?
|
Mitogen-Activated Protein Kinase 7 | 2 | 2008 | 66 | 0.130 |
Why?
|
Succinate Dehydrogenase | 1 | 2016 | 145 | 0.130 |
Why?
|
Specimen Handling | 1 | 2020 | 707 | 0.130 |
Why?
|
Nuclear Receptor Coactivator 2 | 2 | 2006 | 40 | 0.130 |
Why?
|
Lung Diseases | 2 | 2019 | 1915 | 0.130 |
Why?
|
Infant, Newborn, Diseases | 1 | 2021 | 592 | 0.130 |
Why?
|
Ascitic Fluid | 1 | 2015 | 189 | 0.130 |
Why?
|
Survival Rate | 4 | 2024 | 12808 | 0.130 |
Why?
|
Postoperative Hemorrhage | 1 | 2019 | 422 | 0.130 |
Why?
|
Heart Arrest | 2 | 2022 | 1506 | 0.130 |
Why?
|
Societies, Medical | 2 | 2019 | 3905 | 0.120 |
Why?
|
Diagnosis, Differential | 5 | 2024 | 12965 | 0.120 |
Why?
|
Disease-Free Survival | 4 | 2019 | 6828 | 0.120 |
Why?
|
Siblings | 1 | 2019 | 824 | 0.120 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2002 | 1096 | 0.120 |
Why?
|
Critical Illness | 2 | 2020 | 2709 | 0.120 |
Why?
|
Ovarian Diseases | 1 | 2016 | 137 | 0.120 |
Why?
|
Adult | 16 | 2024 | 219994 | 0.120 |
Why?
|
Trans-Activators | 1 | 2004 | 2860 | 0.120 |
Why?
|
Rats, Sprague-Dawley | 2 | 2018 | 8158 | 0.120 |
Why?
|
Treatment Outcome | 13 | 2023 | 65017 | 0.120 |
Why?
|
Ascites | 1 | 2016 | 338 | 0.120 |
Why?
|
Fluorouracil | 3 | 2017 | 1631 | 0.120 |
Why?
|
Combined Modality Therapy | 3 | 2012 | 8552 | 0.120 |
Why?
|
Etoposide | 2 | 2008 | 630 | 0.120 |
Why?
|
Hospital Charges | 1 | 2016 | 359 | 0.120 |
Why?
|
Hepatic Veno-Occlusive Disease | 1 | 2016 | 221 | 0.120 |
Why?
|
Teaching | 1 | 2002 | 1169 | 0.120 |
Why?
|
Estrogen Receptor Modulators | 2 | 2012 | 58 | 0.110 |
Why?
|
Phorbol Esters | 2 | 2005 | 108 | 0.110 |
Why?
|
Kaplan-Meier Estimate | 2 | 2016 | 6544 | 0.110 |
Why?
|
Heart Defects, Congenital | 4 | 2009 | 4673 | 0.110 |
Why?
|
Plasmapheresis | 1 | 2014 | 206 | 0.110 |
Why?
|
Pleural Effusion | 1 | 2016 | 342 | 0.110 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2016 | 791 | 0.110 |
Why?
|
Antihypertensive Agents | 2 | 2023 | 2061 | 0.110 |
Why?
|
Fallopian Tube Neoplasms | 1 | 2015 | 328 | 0.100 |
Why?
|
Physicians | 1 | 2011 | 4591 | 0.100 |
Why?
|
Academies and Institutes | 1 | 2015 | 319 | 0.100 |
Why?
|
Chalcone | 1 | 2012 | 10 | 0.100 |
Why?
|
Wounds and Injuries | 2 | 2003 | 2477 | 0.100 |
Why?
|
Poverty | 1 | 2024 | 2695 | 0.100 |
Why?
|
Luciferases | 3 | 2004 | 716 | 0.100 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 2 | 2004 | 192 | 0.100 |
Why?
|
Hepatectomy | 2 | 2022 | 559 | 0.100 |
Why?
|
Biomedical Research | 2 | 2020 | 3426 | 0.100 |
Why?
|
Skin | 2 | 2019 | 4466 | 0.100 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2021 | 1547 | 0.100 |
Why?
|
Cytodiagnosis | 1 | 2015 | 442 | 0.100 |
Why?
|
Device Removal | 1 | 2016 | 636 | 0.090 |
Why?
|
Kidney Neoplasms | 2 | 2023 | 4312 | 0.090 |
Why?
|
Drug Prescriptions | 1 | 2020 | 1673 | 0.090 |
Why?
|
Sarcoma | 1 | 2022 | 1786 | 0.090 |
Why?
|
Databases, Factual | 2 | 2019 | 8035 | 0.090 |
Why?
|
Phosphatidylinositol 3-Kinases | 3 | 2010 | 2864 | 0.090 |
Why?
|
Doxorubicin | 4 | 2021 | 2209 | 0.090 |
Why?
|
Drainage | 1 | 2016 | 1161 | 0.090 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2012 | 444 | 0.090 |
Why?
|
Positron-Emission Tomography | 2 | 2024 | 6465 | 0.090 |
Why?
|
Signal Transduction | 8 | 2010 | 23376 | 0.090 |
Why?
|
Pain, Postoperative | 1 | 2020 | 1721 | 0.090 |
Why?
|
Aftercare | 1 | 2016 | 916 | 0.090 |
Why?
|
Sickle Cell Trait | 1 | 2010 | 85 | 0.090 |
Why?
|
Genetic Markers | 1 | 2016 | 2608 | 0.090 |
Why?
|
Cyclophosphamide | 2 | 2008 | 2221 | 0.090 |
Why?
|
Congresses as Topic | 1 | 2015 | 805 | 0.090 |
Why?
|
Anesthesia, Local | 1 | 2012 | 276 | 0.090 |
Why?
|
Polyhydramnios | 1 | 2009 | 41 | 0.090 |
Why?
|
Urogenital Surgical Procedures | 1 | 2009 | 35 | 0.080 |
Why?
|
Cystadenoma, Mucinous | 1 | 2009 | 62 | 0.080 |
Why?
|
Gynecomastia | 1 | 2010 | 87 | 0.080 |
Why?
|
Antineoplastic Agents, Phytogenic | 3 | 2002 | 626 | 0.080 |
Why?
|
Proportional Hazards Models | 2 | 2016 | 12531 | 0.080 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2014 | 664 | 0.080 |
Why?
|
Rats | 2 | 2018 | 23711 | 0.080 |
Why?
|
Mesna | 1 | 2008 | 62 | 0.080 |
Why?
|
Chi-Square Distribution | 2 | 2012 | 3465 | 0.080 |
Why?
|
Tamoxifen | 2 | 2004 | 963 | 0.080 |
Why?
|
Age Factors | 4 | 2018 | 18416 | 0.080 |
Why?
|
Multivariate Analysis | 2 | 2012 | 12159 | 0.080 |
Why?
|
Ifosfamide | 1 | 2008 | 232 | 0.080 |
Why?
|
Sarcoma, Synovial | 1 | 2009 | 151 | 0.080 |
Why?
|
Logistic Models | 2 | 2013 | 13314 | 0.080 |
Why?
|
Bone Marrow Transplantation | 2 | 2008 | 2693 | 0.080 |
Why?
|
Surgical Procedures, Operative | 1 | 2019 | 1913 | 0.080 |
Why?
|
Apoptosis Regulatory Proteins | 2 | 2004 | 1135 | 0.080 |
Why?
|
Liver Failure, Acute | 1 | 2009 | 181 | 0.070 |
Why?
|
Time Factors | 6 | 2020 | 40165 | 0.070 |
Why?
|
Estrogen Receptor beta | 2 | 2006 | 168 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 3 | 2010 | 1407 | 0.070 |
Why?
|
Melphalan | 1 | 2008 | 420 | 0.070 |
Why?
|
Lung | 2 | 2019 | 9994 | 0.070 |
Why?
|
Curriculum | 1 | 2020 | 3718 | 0.070 |
Why?
|
Pneumonectomy | 2 | 2017 | 1111 | 0.070 |
Why?
|
Hospitals, Pediatric | 1 | 2016 | 1854 | 0.070 |
Why?
|
Tissue Donors | 2 | 2022 | 2313 | 0.070 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2002 | 3602 | 0.070 |
Why?
|
Anti-Bacterial Agents | 1 | 2005 | 7408 | 0.070 |
Why?
|
Benzamides | 1 | 2012 | 1369 | 0.070 |
Why?
|
Nanostructures | 1 | 2011 | 547 | 0.070 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2008 | 629 | 0.070 |
Why?
|
Prevalence | 2 | 2021 | 15687 | 0.060 |
Why?
|
Genetic Counseling | 1 | 2009 | 624 | 0.060 |
Why?
|
Carboplatin | 1 | 2008 | 788 | 0.060 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2008 | 693 | 0.060 |
Why?
|
Mesoderm | 1 | 2008 | 672 | 0.060 |
Why?
|
Gene Rearrangement | 1 | 2010 | 1122 | 0.060 |
Why?
|
Apigenin | 1 | 2005 | 17 | 0.060 |
Why?
|
Enterocolitis, Necrotizing | 1 | 2009 | 326 | 0.060 |
Why?
|
Sex Distribution | 1 | 2010 | 2295 | 0.060 |
Why?
|
Nuclear Receptor Coactivator 3 | 1 | 2004 | 46 | 0.060 |
Why?
|
Nuclear Receptor Coactivator 1 | 1 | 2004 | 42 | 0.060 |
Why?
|
Transcription, Genetic | 4 | 2010 | 7593 | 0.060 |
Why?
|
Morbidity | 1 | 2010 | 1765 | 0.060 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2008 | 547 | 0.060 |
Why?
|
Transcription Factors | 1 | 2004 | 12103 | 0.060 |
Why?
|
Cohort Studies | 4 | 2020 | 41335 | 0.060 |
Why?
|
Analgesics, Opioid | 1 | 2020 | 3763 | 0.060 |
Why?
|
Infant, Low Birth Weight | 1 | 2009 | 859 | 0.060 |
Why?
|
Quality Improvement | 1 | 2019 | 3836 | 0.060 |
Why?
|
Age Distribution | 1 | 2010 | 2893 | 0.060 |
Why?
|
Receptors, Estrogen | 2 | 2004 | 2210 | 0.060 |
Why?
|
Sepsis | 1 | 2018 | 2592 | 0.060 |
Why?
|
Epithelium | 1 | 2008 | 1605 | 0.060 |
Why?
|
Cathartics | 1 | 2005 | 127 | 0.060 |
Why?
|
Digestive System Surgical Procedures | 1 | 2009 | 575 | 0.060 |
Why?
|
Prospective Studies | 4 | 2023 | 54303 | 0.060 |
Why?
|
Incidental Findings | 1 | 2008 | 698 | 0.060 |
Why?
|
Therapeutic Irrigation | 1 | 2005 | 292 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2010 | 2448 | 0.050 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2002 | 3775 | 0.050 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2008 | 1791 | 0.050 |
Why?
|
Acetyltransferases | 1 | 2004 | 231 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 5 | 2022 | 20509 | 0.050 |
Why?
|
Neuroendocrine Tumors | 1 | 2009 | 650 | 0.050 |
Why?
|
Boston | 1 | 2016 | 9280 | 0.050 |
Why?
|
Leukemia, Radiation-Induced | 1 | 2002 | 39 | 0.050 |
Why?
|
Neoplasm Invasiveness | 1 | 2011 | 3618 | 0.050 |
Why?
|
Response Elements | 1 | 2004 | 308 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 2 | 2009 | 36290 | 0.050 |
Why?
|
Hypertension | 1 | 2023 | 8594 | 0.050 |
Why?
|
Syndrome | 1 | 2009 | 3280 | 0.050 |
Why?
|
Functional Laterality | 1 | 2009 | 2253 | 0.050 |
Why?
|
Antineoplastic Agents | 3 | 2018 | 13630 | 0.050 |
Why?
|
Head and Neck Neoplasms | 1 | 2017 | 2882 | 0.050 |
Why?
|
alpha-Fetoproteins | 1 | 2023 | 222 | 0.050 |
Why?
|
Estradiol | 3 | 2012 | 1932 | 0.050 |
Why?
|
Histone Acetyltransferases | 1 | 2004 | 337 | 0.050 |
Why?
|
Louisiana | 1 | 2002 | 104 | 0.050 |
Why?
|
Catecholamines | 1 | 2023 | 385 | 0.050 |
Why?
|
Flavonoids | 1 | 2005 | 445 | 0.050 |
Why?
|
Hospital Mortality | 2 | 2013 | 5425 | 0.050 |
Why?
|
3-Iodobenzylguanidine | 1 | 2022 | 114 | 0.050 |
Why?
|
Mitotane | 1 | 2021 | 20 | 0.050 |
Why?
|
Ultrasonography, Prenatal | 1 | 2009 | 1745 | 0.050 |
Why?
|
Quality of Life | 2 | 2022 | 13308 | 0.050 |
Why?
|
Genes, Dominant | 1 | 2004 | 863 | 0.050 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2010 | 2418 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2019 | 5397 | 0.050 |
Why?
|
Organizational Case Studies | 1 | 2002 | 301 | 0.050 |
Why?
|
Wound Healing | 1 | 2012 | 2788 | 0.050 |
Why?
|
Resuscitation Orders | 1 | 2003 | 270 | 0.050 |
Why?
|
Enzyme Activation | 2 | 2004 | 3602 | 0.050 |
Why?
|
Gestational Age | 1 | 2009 | 3565 | 0.050 |
Why?
|
Carcinosarcoma | 1 | 2001 | 104 | 0.050 |
Why?
|
Groin | 1 | 2021 | 107 | 0.040 |
Why?
|
Inhibitory Concentration 50 | 1 | 2001 | 465 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2002 | 1246 | 0.040 |
Why?
|
Desmoplastic Small Round Cell Tumor | 1 | 2020 | 33 | 0.040 |
Why?
|
Pancreatectomy | 2 | 2021 | 810 | 0.040 |
Why?
|
Oncogene Proteins | 1 | 2004 | 719 | 0.040 |
Why?
|
Odds Ratio | 1 | 2012 | 9716 | 0.040 |
Why?
|
Melanoma | 1 | 2019 | 5697 | 0.040 |
Why?
|
Carcinogens | 1 | 2002 | 449 | 0.040 |
Why?
|
Neurosurgical Procedures | 1 | 2011 | 2056 | 0.040 |
Why?
|
Organometallic Compounds | 1 | 2024 | 662 | 0.040 |
Why?
|
Reoperation | 2 | 2009 | 4291 | 0.040 |
Why?
|
Sphingomyelin Phosphodiesterase | 1 | 2000 | 82 | 0.040 |
Why?
|
Cell Line, Tumor | 5 | 2012 | 16939 | 0.040 |
Why?
|
Disease Progression | 1 | 2016 | 13502 | 0.040 |
Why?
|
Tissue Banks | 1 | 2020 | 184 | 0.040 |
Why?
|
Abdominal Wall | 1 | 2021 | 165 | 0.040 |
Why?
|
Skin Neoplasms | 1 | 2019 | 5799 | 0.040 |
Why?
|
Membrane Proteins | 1 | 2016 | 7850 | 0.040 |
Why?
|
Severity of Illness Index | 1 | 2017 | 15840 | 0.040 |
Why?
|
Adrenalectomy | 1 | 2021 | 348 | 0.040 |
Why?
|
Neoplasms, Hormone-Dependent | 1 | 2001 | 412 | 0.040 |
Why?
|
Longitudinal Studies | 2 | 2018 | 14495 | 0.040 |
Why?
|
Proteomics | 2 | 2010 | 3817 | 0.040 |
Why?
|
Heart-Assist Devices | 1 | 2009 | 1291 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2016 | 7475 | 0.040 |
Why?
|
Carcinoma, Papillary | 1 | 2004 | 785 | 0.040 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2009 | 1724 | 0.040 |
Why?
|
Risk Assessment | 2 | 2018 | 24123 | 0.040 |
Why?
|
Radionuclide Imaging | 1 | 2022 | 1975 | 0.040 |
Why?
|
Fatal Outcome | 1 | 2002 | 1832 | 0.040 |
Why?
|
Imaging, Three-Dimensional | 1 | 2011 | 4048 | 0.040 |
Why?
|
Middle Aged | 8 | 2021 | 220352 | 0.040 |
Why?
|
Immunohistochemistry | 1 | 2011 | 11071 | 0.040 |
Why?
|
Genes, Reporter | 1 | 2001 | 1529 | 0.040 |
Why?
|
International Agencies | 1 | 2018 | 244 | 0.040 |
Why?
|
Paclitaxel | 2 | 2001 | 1736 | 0.040 |
Why?
|
Cell Division | 1 | 2004 | 4463 | 0.030 |
Why?
|
Immunoglobulin G | 1 | 2008 | 4541 | 0.030 |
Why?
|
Phosphorylation | 2 | 2006 | 8313 | 0.030 |
Why?
|
North America | 1 | 2020 | 1284 | 0.030 |
Why?
|
Constipation | 1 | 2020 | 561 | 0.030 |
Why?
|
Rare Diseases | 1 | 2021 | 619 | 0.030 |
Why?
|
Methotrexate | 1 | 2002 | 1719 | 0.030 |
Why?
|
Ceramides | 3 | 2003 | 201 | 0.030 |
Why?
|
Carcinoma, Renal Cell | 1 | 2010 | 3218 | 0.030 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2003 | 1004 | 0.030 |
Why?
|
Prostheses and Implants | 1 | 2021 | 1273 | 0.030 |
Why?
|
Lymph Node Excision | 1 | 2021 | 1303 | 0.030 |
Why?
|
Pyridostigmine Bromide | 1 | 2014 | 31 | 0.030 |
Why?
|
Hospitalization | 1 | 2014 | 10790 | 0.030 |
Why?
|
Pathology, Surgical | 1 | 2015 | 151 | 0.030 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2019 | 733 | 0.030 |
Why?
|
Animals | 3 | 2018 | 167963 | 0.030 |
Why?
|
Lower Extremity | 1 | 2022 | 1194 | 0.030 |
Why?
|
Algorithms | 1 | 2014 | 13981 | 0.030 |
Why?
|
Pregnancy | 3 | 2012 | 29749 | 0.030 |
Why?
|
Camptothecin | 1 | 2017 | 590 | 0.030 |
Why?
|
Cleft Palate | 1 | 2019 | 587 | 0.030 |
Why?
|
Enzyme Inhibitors | 1 | 2004 | 3726 | 0.030 |
Why?
|
Canada | 1 | 2018 | 2128 | 0.030 |
Why?
|
Atrophy | 1 | 2018 | 1627 | 0.030 |
Why?
|
Scoliosis | 1 | 2019 | 735 | 0.030 |
Why?
|
Transfection | 3 | 2010 | 5781 | 0.030 |
Why?
|
Nerve Fibers | 1 | 1996 | 708 | 0.030 |
Why?
|
Myelodysplastic Syndromes | 1 | 2002 | 1394 | 0.030 |
Why?
|
Mutation | 1 | 2016 | 29932 | 0.020 |
Why?
|
Emergency Service, Hospital | 2 | 2020 | 7818 | 0.020 |
Why?
|
Radiotherapy | 1 | 2018 | 1504 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2008 | 9185 | 0.020 |
Why?
|
Age of Onset | 1 | 2018 | 3301 | 0.020 |
Why?
|
Emergency Medical Services | 1 | 2003 | 1925 | 0.020 |
Why?
|
Vinculin | 1 | 2010 | 59 | 0.020 |
Why?
|
Esophageal Neoplasms | 1 | 2001 | 1648 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2021 | 5201 | 0.020 |
Why?
|
Kidney Medulla | 1 | 2010 | 169 | 0.020 |
Why?
|
Gene Expression Profiling | 2 | 2008 | 9411 | 0.020 |
Why?
|
Spinal Fusion | 1 | 2019 | 1281 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2021 | 2821 | 0.020 |
Why?
|
Operating Rooms | 1 | 2016 | 789 | 0.020 |
Why?
|
Macaca mulatta | 1 | 1996 | 2316 | 0.020 |
Why?
|
Delayed Graft Function | 1 | 2009 | 49 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2021 | 3486 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2017 | 4899 | 0.020 |
Why?
|
Tumor Stem Cell Assay | 1 | 2008 | 115 | 0.020 |
Why?
|
Factor XIII | 1 | 1989 | 59 | 0.020 |
Why?
|
Aprotinin | 1 | 1989 | 94 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2021 | 25942 | 0.020 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2008 | 283 | 0.020 |
Why?
|
Temporal Lobe | 1 | 1996 | 1688 | 0.020 |
Why?
|
Gene Expression | 1 | 2001 | 7588 | 0.020 |
Why?
|
Hemostasis, Surgical | 1 | 1989 | 129 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2008 | 4573 | 0.020 |
Why?
|
Hemochromatosis | 1 | 2009 | 174 | 0.020 |
Why?
|
Germ-Line Mutation | 1 | 2016 | 1841 | 0.020 |
Why?
|
Sternum | 1 | 1989 | 175 | 0.020 |
Why?
|
Cell Proliferation | 2 | 2019 | 10446 | 0.020 |
Why?
|
Blotting, Western | 2 | 2008 | 5039 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2000 | 4490 | 0.020 |
Why?
|
Length of Stay | 2 | 2019 | 6479 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2021 | 3527 | 0.020 |
Why?
|
Tissue Adhesives | 1 | 1989 | 173 | 0.020 |
Why?
|
Diet | 1 | 2005 | 8010 | 0.020 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2016 | 1200 | 0.020 |
Why?
|
MAP Kinase Kinase 6 | 1 | 2006 | 20 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2008 | 17790 | 0.020 |
Why?
|
Thrombin | 1 | 1989 | 593 | 0.020 |
Why?
|
Recurrence | 1 | 2018 | 8482 | 0.020 |
Why?
|
Fibrinogen | 1 | 1989 | 886 | 0.020 |
Why?
|
Health Status | 1 | 2018 | 4081 | 0.020 |
Why?
|
Patient Readmission | 1 | 2019 | 3323 | 0.020 |
Why?
|
Chromatography, Liquid | 1 | 2008 | 987 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2016 | 5785 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2008 | 2471 | 0.010 |
Why?
|
Organ Size | 1 | 2009 | 2254 | 0.010 |
Why?
|
Kidney | 1 | 2019 | 7064 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2016 | 5508 | 0.010 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2010 | 1613 | 0.010 |
Why?
|
HEK293 Cells | 1 | 2012 | 4264 | 0.010 |
Why?
|
Benchmarking | 1 | 2009 | 1044 | 0.010 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2010 | 1596 | 0.010 |
Why?
|
Electrocardiography | 2 | 2003 | 6414 | 0.010 |
Why?
|
Tandem Mass Spectrometry | 1 | 2008 | 1189 | 0.010 |
Why?
|
DNA Methylation | 1 | 2016 | 4373 | 0.010 |
Why?
|
Transportation of Patients | 1 | 2003 | 176 | 0.010 |
Why?
|
Glycine-tRNA Ligase | 1 | 2001 | 2 | 0.010 |
Why?
|
Receptors, Laminin | 1 | 2001 | 26 | 0.010 |
Why?
|
Glycogen Synthase Kinases | 1 | 2001 | 40 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2018 | 8056 | 0.010 |
Why?
|
Peptide Elongation Factor 1 | 1 | 2001 | 39 | 0.010 |
Why?
|
Genes, bcl-2 | 1 | 2001 | 119 | 0.010 |
Why?
|
Up-Regulation | 1 | 2010 | 4122 | 0.010 |
Why?
|
Tissue and Organ Procurement | 1 | 2009 | 944 | 0.010 |
Why?
|
Thoracotomy | 1 | 2003 | 363 | 0.010 |
Why?
|
Brain Mapping | 1 | 1996 | 6568 | 0.010 |
Why?
|
Birth Weight | 1 | 2009 | 2097 | 0.010 |
Why?
|
RNA, Messenger | 2 | 2008 | 12766 | 0.010 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2001 | 489 | 0.010 |
Why?
|
Imidazoles | 1 | 2006 | 1180 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2008 | 3442 | 0.010 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2001 | 410 | 0.010 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 2000 | 818 | 0.010 |
Why?
|
Biopsy, Needle | 1 | 2004 | 1630 | 0.010 |
Why?
|
Cell Death | 1 | 2003 | 1672 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2010 | 17624 | 0.010 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2001 | 675 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2010 | 4407 | 0.010 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2000 | 617 | 0.010 |
Why?
|
Fibronectins | 1 | 2001 | 722 | 0.010 |
Why?
|
Esophagectomy | 1 | 2001 | 466 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2010 | 4938 | 0.010 |
Why?
|
Pancreas | 1 | 2004 | 1677 | 0.010 |
Why?
|
Drug Interactions | 1 | 2001 | 1428 | 0.010 |
Why?
|
DNA Primers | 1 | 2001 | 2819 | 0.010 |
Why?
|
Wheat Germ Agglutinin-Horseradish Peroxidase Conjugate | 1 | 1996 | 35 | 0.010 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 1998 | 585 | 0.010 |
Why?
|
Aged | 2 | 2020 | 169152 | 0.010 |
Why?
|
Caspases | 1 | 1998 | 878 | 0.010 |
Why?
|
Protein Isoforms | 1 | 2000 | 1697 | 0.010 |
Why?
|
Esophagus | 1 | 2001 | 1023 | 0.010 |
Why?
|
Plasmids | 1 | 2000 | 2275 | 0.010 |
Why?
|
Pulmonary Veins | 2 | 1988 | 745 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2010 | 8515 | 0.010 |
Why?
|
Fibroblast Growth Factors | 1 | 2000 | 869 | 0.010 |
Why?
|
Pyridines | 1 | 2006 | 2879 | 0.010 |
Why?
|
Injections | 1 | 1996 | 830 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2011 | 20080 | 0.010 |
Why?
|
Body Mass Index | 1 | 2010 | 12914 | 0.010 |
Why?
|
Auditory Cortex | 1 | 1996 | 362 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 1988 | 8950 | 0.010 |
Why?
|
Parietal Lobe | 1 | 1996 | 850 | 0.010 |
Why?
|
Phenotype | 1 | 2008 | 16546 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2000 | 6538 | 0.010 |
Why?
|
Frontal Lobe | 1 | 1996 | 1420 | 0.010 |
Why?
|
Venae Cavae | 1 | 1988 | 41 | 0.010 |
Why?
|
Fibrin Tissue Adhesive | 1 | 1989 | 86 | 0.000 |
Why?
|
Visual Cortex | 1 | 1996 | 1089 | 0.000 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2000 | 10827 | 0.000 |
Why?
|
Obesity | 1 | 2010 | 12922 | 0.000 |
Why?
|
Models, Biological | 1 | 2003 | 9467 | 0.000 |
Why?
|
Cell Line | 1 | 2000 | 15620 | 0.000 |
Why?
|
Neural Pathways | 1 | 1996 | 3040 | 0.000 |
Why?
|
Random Allocation | 1 | 1989 | 2394 | 0.000 |
Why?
|
Heart Valve Prosthesis | 1 | 1972 | 1495 | 0.000 |
Why?
|
Hepatitis B | 1 | 1989 | 701 | 0.000 |
Why?
|
HIV Seropositivity | 1 | 1989 | 955 | 0.000 |
Why?
|
Drug Combinations | 1 | 1989 | 2025 | 0.000 |
Why?
|
Angiocardiography | 2 | 1972 | 153 | 0.000 |
Why?
|
Emergencies | 1 | 1989 | 1211 | 0.000 |
Why?
|
Aorta | 1 | 1988 | 2039 | 0.000 |
Why?
|
Pulmonary Artery | 1 | 1988 | 1921 | 0.000 |
Why?
|
Hepatitis C | 1 | 1989 | 1579 | 0.000 |
Why?
|
Myocardium | 1 | 1988 | 4700 | 0.000 |
Why?
|
Extracorporeal Circulation | 1 | 1972 | 182 | 0.000 |
Why?
|
Tricuspid Valve | 1 | 1972 | 409 | 0.000 |
Why?
|
Pulmonary Circulation | 1 | 1972 | 743 | 0.000 |
Why?
|
Thromboembolism | 1 | 1972 | 1017 | 0.000 |
Why?
|
Body Height | 1 | 1972 | 1570 | 0.000 |
Why?
|
Heart Valve Diseases | 1 | 1972 | 1047 | 0.000 |
Why?
|
Mitral Valve | 1 | 1972 | 1486 | 0.000 |
Why?
|
Arrhythmias, Cardiac | 1 | 1972 | 2255 | 0.000 |
Why?
|
Aortic Valve | 1 | 1972 | 1996 | 0.000 |
Why?
|
Body Weight | 1 | 1972 | 4611 | 0.000 |
Why?
|
Heart Failure | 1 | 1972 | 11847 | 0.000 |
Why?
|